CTM

Proteogenomic characterization of bladder cancer reveals sensitivity to TRAIL-induced apoptosis in FGFR3-mutated tumors.

Equipe DesCarTes Groeneveld CS, Sanchez-Quiles V, Dufour F, Shi M, Dingli F, Nicolle R, Chapeaublanc E, Poullet P, Jeffery D, Krucker C, Maillé P, Vacherot F, Vordos D, Benhamou S, Lebret T, Micheau O, Zinovyev A, Loew D, Allory Y, de Reyniès A, Bernard-Pierrot I, Radvanyi F. European Urology 2024, May;85(5):483-494. Background Molecular understanding of … Lire la suite

TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling

Equipe DesCarTes Guerrache A & Micheau O Cells 2024, 13(6), 521; https://doi.org/10.3390/cells13060521 TNF-related apoptosis-inducing ligand (TRAIL or Apo2 or TNFSF10) belongs to the TNF superfamily. When bound to its agonistic receptors, TRAIL can induce apoptosis in tumour cells, while sparing healthy cells. Over the last three decades, this tumour selectivity has prompted many studies aiming at evaluating the … Lire la suite

Dr Jérôme Devy Lundi 13 Mai 2024

Contribution of the Low-Density Lipoprotein Receptor Family to Breast Cancer Progression (Amphi Masson) CTM U1231 SCIENTIFIC SEMINAR   May 13, 2024 1 to 2 pm, UFR des Sciences de Santé, Amphi Masson Chairman: Dr Olivier Micheau Invited speaker: Dr Jérôme Devy UMR CNRS/URCA 7369 – MEDyc Reims, France   Contribution of the Low-Density Lipoprotein Receptor … Lire la suite